Package 61703-155-01

Brand: cytarabine

Generic: cytarabine
NDC Package

Package Facts

Identity

Package NDC 61703-155-01
Digits Only 6170315501
Product NDC 61703-155
Product ID 61703-155_e3a8c0e9-19ed-49b7-8464-11e8806f47fd
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (61703-155-01) / 20 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2025-04-07
Brand cytarabine
Generic cytarabine
Sample Package No

Linked Drug Pages (1)

Cytarabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRATHECAL", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "e3a8c0e9-19ed-49b7-8464-11e8806f47fd", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["04079A1RDZ"], "rxcui": ["249364"], "spl_set_id": ["e3a8c0e9-19ed-49b7-8464-11e8806f47fd"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (61703-155-01)  / 20 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "61703-155-01", "marketing_start_date": "20250407"}], "brand_name": "Cytarabine", "product_id": "61703-155_e3a8c0e9-19ed-49b7-8464-11e8806f47fd", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "61703-155", "generic_name": "CYTARABINE", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cytarabine", "active_ingredients": [{"name": "CYTARABINE", "strength": "100 mg/mL"}], "application_number": "ANDA075383", "marketing_category": "ANDA", "marketing_start_date": "20250407", "listing_expiration_date": "20261231"}